Biote Capex To Operating Cash Flow from 2010 to 2024

BTMD Stock  USD 6.61  0.07  1.05%   
Biote Corp's Capex To Operating Cash Flow is decreasing over the years with stable fluctuation. Overall, Capex To Operating Cash Flow is expected to go to 0.11 this year. During the period from 2010 to 2024 Biote Corp Capex To Operating Cash Flow annual values regression line had coefficient of variation of  131.51 and r-squared of  0.02. View All Fundamentals
 
Capex To Operating Cash Flow  
First Reported
2010-12-31
Previous Quarter
0.1009188
Current Value
0.11
Quarterly Volatility
0.07322932
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Biote Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biote Corp's main balance sheet or income statement drivers, such as Tax Provision of 6.2 M, Depreciation And Amortization of 1.9 M or Interest Expense of 3.9 M, as well as many indicators such as Price To Sales Ratio of 0.61, Dividend Yield of 0.065 or Days Sales Outstanding of 11.3. Biote financial statements analysis is a perfect complement when working with Biote Corp Valuation or Volatility modules.
  
Check out the analysis of Biote Corp Correlation against competitors.
For information on how to trade Biote Stock refer to our How to Trade Biote Stock guide.

Latest Biote Corp's Capex To Operating Cash Flow Growth Pattern

Below is the plot of the Capex To Operating Cash Flow of biote Corp over the last few years. It is Biote Corp's Capex To Operating Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biote Corp's overall financial position and show how it may be relating to other accounts over time.
Capex To Operating Cash Flow10 Years Trend
Pretty Stable
   Capex To Operating Cash Flow   
       Timeline  

Biote Capex To Operating Cash Flow Regression Statistics

Arithmetic Mean0.06
Coefficient Of Variation131.51
Mean Deviation0.03
Median0.07
Standard Deviation0.07
Sample Variance0.01
Range0.3136
R-Value(0.15)
Mean Square Error0.01
R-Squared0.02
Significance0.60
Slope(0)
Total Sum of Squares0.08

Biote Capex To Operating Cash Flow History

2023 0.1
2022 -0.2
2021 0.11
2020 0.0527

About Biote Corp Financial Statements

Biote Corp stakeholders use historical fundamental indicators, such as Biote Corp's Capex To Operating Cash Flow, to determine how well the company is positioned to perform in the future. Although Biote Corp investors may analyze each financial statement separately, they are all interrelated. For example, changes in Biote Corp's assets and liabilities are reflected in the revenues and expenses on Biote Corp's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in biote Corp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capex To Operating Cash Flow 0.10  0.11 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether biote Corp is a strong investment it is important to analyze Biote Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Biote Corp's future performance. For an informed investment choice regarding Biote Stock, refer to the following important reports:
Check out the analysis of Biote Corp Correlation against competitors.
For information on how to trade Biote Stock refer to our How to Trade Biote Stock guide.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biote Corp. If investors know Biote will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biote Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.375
Earnings Share
0.3
Revenue Per Share
5.767
Quarterly Revenue Growth
0.128
Return On Assets
0.1816
The market value of biote Corp is measured differently than its book value, which is the value of Biote that is recorded on the company's balance sheet. Investors also form their own opinion of Biote Corp's value that differs from its market value or its book value, called intrinsic value, which is Biote Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biote Corp's market value can be influenced by many factors that don't directly affect Biote Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biote Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biote Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biote Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.